9.78BMarket Cap
27.92P/E TTM
Halozyme Therapeutics Inc
HALO Balance Sheet
You can check out the annual or quarterly balance sheets of Halozyme Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing HALO stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Halozyme Therapeutics Inc Have?
In its most recent quarterly, Halozyme Therapeutics Inc had 309.75M in cash and cash equivalents.
How Much Are Halozyme Therapeutics Inc's Total Liabilities?
Halozyme Therapeutics Inc reported 2.48B in total liabilities as of the latest reported quarter, including 177.09M in current liabilities and 2.30B in non-current liabilities.
What Are Halozyme Therapeutics Inc's Total Assets?
As of the latest reported quarter, Halozyme Therapeutics Inc's total assets were 2.53B, consisting of 825.21M in current assets and 1.70B in non-current assets.
How Much Shareholders' Equity Does Halozyme Therapeutics Inc Have?
Halozyme Therapeutics Inc reported 48.81M in total shareholders' equity as of the latest reported quarter.